On the other hand, although various studies have been undertaken to clarify the factors contributing to the response to IFN-based therapy in genotype 1 infection, it remains poorly understood which patients with genotype 2b HCV infection will show unfavorable responses. The gene discussed is IFNA1; the disease is infection.